Follow
Cessatech A/S
Spotlight (Sweden)
Cessatech is a Danish clinical Phase II company developing evidence-based treatment for children. Its lead asset (CT001) is an analgesic nasal spray for treatment of acute and planned painful procedures in children.
Sector:
HEALTH CARE
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
CESSA
DK0061411964
Spotlight
Sweden (SE)
Details of share in Cessatech A/S with ticker CESSA
Status
Inactive
Order book id
Amount of instruments
Par value
Market cap
Currency
DKK
First trading date
16 Dec 2020
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
9.40 DKK
18.8M DKK
10 Nov - 24 Nov 2020
IPO in Cessatech A/S
Type
Ticker
ISIN
Market
OPTION
CESSA TO1
DK0061416849
Spotlight
Sweden (SE)
Details of option in Cessatech A/S with ticker CESSA TO1
Status
Inactive
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
16 Dec 2020
Terms
Type
Price
Pre-money valuation
Time
Files
Exercise
25 Nov - 16 Dec 2021
Option exercise terms for CESSA TO1
People
Jes Trygved
CEO
Ulla Buhl
Chairman of the board
Martin Olin
Board member
Adam Steensberg
Board member
Flemming Steen Jensen
Board member
Charlotte Videbæk
Board member
Peter Birk
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Fruebjergvej 3
Zip code
2100
City/district
Copenhagen
Country
Denmark (DK)
Phones
Registration number
41293055
LEI code
549300WO5SKVXWPOXR16
First trade date
16 Dec 2020
Registration date
06 Apr 2020
Short name
Cessatech

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date